Form 8-K - Current report:
SEC Accession No. 0001628280-23-007952
Filing Date
2023-03-15
Accepted
2023-03-15 07:39:01
Documents
18
Period of Report
2023-03-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cpix-20230315.htm   iXBRL 8-K 42588
5 EX-10.11 ajkazimiemploymentagreemen.htm EX-10.11 37289
6 EX-10.14 chrisbittermanemploymentag.htm EX-10.14 34416
7 GRAPHIC image_0.jpg GRAPHIC 39614
8 EX-10.12 jameshermanemploymentagree.htm EX-10.12 34506
9 EX-10.15 johnhammemploymentagreemen.htm EX-10.15 34347
10 EX-10.13 toddanthony-employmentagre.htm EX-10.13 34404
  Complete submission text file 0001628280-23-007952.txt   448187

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20230315.xsd EX-101.SCH 2011
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20230315_lab.xml EX-101.LAB 24137
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20230315_pre.xml EX-101.PRE 12609
12 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20230315_htm.xml XML 4279
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 23733296
SIC: 2834 Pharmaceutical Preparations